Parsonage Turner Syndrome Following COVID-19 Vaccine
Article Main Content
Parsonage Turner Syndrome (PTS) presents with sudden onset arm pain followed by motor weakness and can be associated with surgery, infection, or vaccination. This case discusses an incidence of PTS following COVID-19 vaccination where symptoms resolved on their own progressively and extensive investigations ruled out cerebrovascular accident or vascular aetiology, and diagnosis of PTS was made. Incidence of such adverse effects is rare and awareness among clinical community can lead to recognition and prompt management of such cases.
References
- 
		                                    
			                                    Van Eijk JJ, Groothuis JT, Van Alfen N. Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment. Muscle Nerve. 2016; 53(3): 337‐350. 
                                                
                                                
  DOI
 | DOI
 |Google Scholar 1
- 
		                                    
			                                    Ferrante MA, Wilbourn AJ. Lesion distribution among 281 patients with sporadic neuralgic amyotrophy. Muscle Nerve. 2017; 55: 858‐861. 
                                                
                                                
  DOI
 | DOI
 |Google Scholar 2
- 
		                                    
			                                    Siepmann T, Kitzler HH, Lueck C, Platzek I, Reichmann H, Barlinn K. Neuralgic amyotrophy following infection with SARS‐CoV‐2. Muscle Nerve. 2020; 62: E68‐E70. 
                                                
                                                
  DOI
 | DOI
 |Google Scholar 3
- 
		                                    
			                                    Mahajan S, Zhang F, Mahajan A, Zimnowodzki S. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve. 2021; 64(1): E3-E4. 
                                                
                                                
  DOI
 | DOI
 |Google Scholar 4
- 
		                                    
			                                    Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID‐19 vaccine. New England Journal of Medicine. 2020; 383: 2603‐2615. 
                                                
                                                
  DOI
 | DOI
 |Google Scholar 5
- 
		                                    
			                                    an Alfen N, van Eijk JJJ, Ennik T, Flynn SO, Nobacht IEG, Groothuis JT, et al. Incidence of Neuralgic Amyotrophy (Parsonage Turner Syndrome) in a Primary Care Setting - A Prospective Cohort Study. PLoS ONE. 2015; 10(5): e0128361. 
                                                
                                                
  DOI
 | DOI
 |Google Scholar 6
- 
		                                    
			                                    Vaccine adverse effect reporting system (VAERS). United States Department of Health and Human Services (DHHS), Public Health Service (PHS), Centers for Disease Control (CDC)/Food and Drug Administration (FDA), Vaccine Adverse Reporting System (VAERS) 1990‐3/19/2021, CDC Wonder On‐line Database. [Internet] 2021 [cited 2021 November 29] Available from: http://wonder.cdc.gov/vaers.html. 
                                                
                                                
 Google Scholar 7
Most read articles by the same author(s)
- 
													Sohaib Bin Nawaz,
						                        
 Chronic Ruptured Abdominal Aortic Aneurysm , European Journal of Medical and Health Sciences: Vol. 4 No. 1 (2022)
 
					 
								 
  
						 
						 
						




